Briefings in BioinformaticsPharmacology & ToxicologyPeer-reviewed journal article
Contrastive learning of adverse events to provide effective and interpretable vector representations for machine-assisted pharmacovigilance
Olivér M. BaloghiD, Mátyás PéterváriiD, Áron Márk Csernák, Eszter PuhliD, András HorváthiD, Péter FerdinandyiD, Bence ÁggiD
Abstract
Post-marketing surveillance is crucial for drug safety, yet the tools of pharmacovigilance rely solely on text-based data that may limit the applicability of contemporary machine learning methodologies in the support of decision making. Here, we adapt contrastive learning algorithms to generate adverse event vector representations from spontaneous reports to serve as general machine-readable resources for pharmacovigilance applications. We present comprehensive analyses of the resulting representations through density-based clustering, semantic evaluation and comparison of multivariate dispersions, revealing patterns that reflect both functional and causal relations of the adverse events while also capturing drug-safety related information better than existing medical terminologies and encoder-only large language models (LLMs). Furthermore, we demonstrate the applicability of the representations as input features in our downstream model, outperforming the reporting odds ratio method commonly used by regulatory agencies (AUROC: 0.88 vs 0.75) and LLM-based representations (AUROC: 0.88 vs 0.83) on drug-event causality prediction benchmarks. As such, this is the first demonstration of an interpretable adverse event vector representation that can be utilized for training arbitrary models, enabling wider and more effective applications of machine learning in pharmacovigilance.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 0th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- aer2vec: Distributed Representations of Adverse Event Reporting System Data as a Means to Identify Drug/Side-Effect Associations
Jake Portanova, Nathan B. Murray, … Trevor Cohen·bioRxiv·Oct 2, 2019
- The assessment of similarity vectors of fingerprint and UMLS in adverse drug reaction prediction
Milad Besharatifard, Zahra Ghorbanali, Fatemeh Zare‐Mirakabad·bioRxiv·Nov 15, 2021
- Improved Automatic Pharmacovigilance: An Enhancement to the MedWatcher Social System for Monitoring Adverse Events
André T. Nguyen, Julia Lien, … Sumiko R. Mekaru·bioRxiv·Sep 22, 2019
- MultiGML: Multimodal Graph Machine Learning for Prediction of Adverse Drug Events
Sophia Krix, Lauren Nicole DeLong, … Holger Fröhlich·HeliyonPeer-reviewed·Aug 27, 2023
- Predicting the Frequency of Drug Side effects
Diego Galeano, Alberto Paccanaro·bioRxiv·Mar 31, 2019
- The Importance of Reverse Translation for Preclinical Off-Target Mitigation: Quantification and Mitigation of Biases in the FDA Adverse Event Reporting System
M. Maciejewski, E. Lounkine, … L. Urban·bioRxiv·Aug 14, 2016